More specifically, loss of the X-linked gene Lysine Demethylase 6A (KDM6A) resulted in a gender-specific aberrant activation of a set of enhancers leading to an aggressive phenotype of pancreatic cancer [68]. This evidence concerns the gene KDM6A and familial pancreatic carcinoma.